Thursday, November 20, 2025
HomeHealth

Health

Moderna's sales target cut is in sharp contrast to that of larger rival Pfizer Inc, which earlier this week raised its sales forecast for...
The U.K. is the first country to approve Merck's molnupiravir antiviral treatment for COVID-19.
Provinces may run into challenges funding health-care systems post-COVID-19 after the pandemic has forced recorded spending, a new report indicates.
The territory has not yet determined any consequences for those who refuse to comply to the new rule.

Recent posts